| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Solutions
1 company
Kuppusamy Karthik is a SVP, Clinical Solutions at DGX. Recent filings cover 0 purchases and 9 sales. Those positions are worth an estimated $3.2M at current prices.
Our model assigns Kuppusamy Karthik a below-average insider score of 30/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -25.7%.
Kuppusamy Karthik's largest disclosed position is in DGX as SVP, Clinical Solutions, worth about $3.2M. The recent filings there lean toward selling, a net 29,334 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | DGX Quest Diagnostics Incorporated | SVP, Clinical Solutions | Sale+OE | 8,147 | $200.00 | $1,629,400.00 | -37.6% | +22.8% | - | |
| Mar 4, 2026 | DGX Quest Diagnostics Incorporated | SVP, Clinical Solutions | Sell | 2,628 | $204.86 | $538,372.08 | -16.4% | -7.3% | - | |
| Jul 31, 2025 | DGX Quest Diagnostics Inc | SVP, Clinical Solutions | Sale+OE | 10,479 | $167.95 | $1,759,930.60 | -55.4% | +4.4% | +39.2% | |
| Apr 2, 2025 | DGX Quest Diagnostics Inc | SVP, Clinical Solutions | Sell | 2,555 | $170.00 | $434,350.00 | -19.5% | +6.8% | +17.9% | |
| Oct 28, 2024 | DGX Quest Diagnostics Inc | SVP, Clinical Solutions | Sell | 1,775 | $156.92 | $278,525.19 | -15.4% | +2.6% | +14.3% | |
| Aug 28, 2024 | DGX Quest Diagnostics Inc | SVP, Clinical Solutions | Sell | 1,990 | $153.26 | $304,989.79 | -14.8% | +4.8% | +15.7% | |
| Apr 29, 2024 | DGX Quest Diagnostics Inc | SVP, Clinical Solutions | Sell | 1,760 | $140.00 | $246,400.00 | -11.6% | +1.9% | +28.0% |